Overview

Assessment of GRT6005 in Painful Osteoarthritis of the Knee

Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The purpose of the trial is to determine whether GRT6005 is effective in patients with pain due to osteoarthritis of the knee.
Phase:
Phase 2
Details
Lead Sponsor:
Grünenthal GmbH
Tris Pharma, Inc.
Collaborator:
Forest Laboratories